Notably, there were numerous oncogenic pathways upregulated in the low-TRPV1-expression subgroup, including pathways in cancer, small cell lung cancer, Jak-STAT signaling, p53 signaling, and calcium signaling (Figure 5(b)). This evidence concerns the gene TRPV1 and cancer.